Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 59 | 2024 | 3245 | 7.280 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 18 | 2024 | 558 | 3.280 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 7 | 2024 | 256 | 2.830 |
Why?
|
Magnetic Resonance Imaging | 79 | 2024 | 36840 | 2.220 |
Why?
|
Cerebral Cortex | 18 | 2024 | 5827 | 1.910 |
Why?
|
Receptors, GABA | 5 | 2024 | 313 | 1.540 |
Why?
|
Positron-Emission Tomography | 13 | 2024 | 6657 | 1.090 |
Why?
|
Meninges | 2 | 2024 | 197 | 0.970 |
Why?
|
Brain | 38 | 2024 | 27438 | 0.930 |
Why?
|
Spinal Cord | 8 | 2024 | 1814 | 0.920 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2020 | 3408 | 0.890 |
Why?
|
Brain Mapping | 18 | 2019 | 6740 | 0.740 |
Why?
|
Myelin Sheath | 5 | 2024 | 653 | 0.660 |
Why?
|
Trigeminal Nerve | 2 | 2014 | 248 | 0.660 |
Why?
|
Nerve Degeneration | 2 | 2017 | 750 | 0.660 |
Why?
|
Migraine with Aura | 3 | 2020 | 204 | 0.650 |
Why?
|
Hemostatics | 1 | 2021 | 246 | 0.620 |
Why?
|
Pyrimidines | 4 | 2024 | 3050 | 0.620 |
Why?
|
Interferon-beta | 5 | 2015 | 348 | 0.600 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2015 | 953 | 0.590 |
Why?
|
Thalamus | 4 | 2020 | 1051 | 0.580 |
Why?
|
Periaqueductal Gray | 2 | 2016 | 111 | 0.490 |
Why?
|
Atrophy | 10 | 2024 | 1648 | 0.470 |
Why?
|
Disease Progression | 17 | 2024 | 13655 | 0.470 |
Why?
|
Somatosensory Cortex | 4 | 2013 | 516 | 0.470 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2019 | 2823 | 0.470 |
Why?
|
Microglia | 2 | 2023 | 1376 | 0.450 |
Why?
|
Inflammation | 5 | 2024 | 10865 | 0.440 |
Why?
|
Meningitis | 1 | 2015 | 219 | 0.430 |
Why?
|
Neural Pathways | 4 | 2016 | 3122 | 0.410 |
Why?
|
Migraine without Aura | 1 | 2013 | 82 | 0.410 |
Why?
|
Paraparesis, Tropical Spastic | 1 | 2012 | 32 | 0.400 |
Why?
|
Leukoencephalopathies | 3 | 2022 | 261 | 0.390 |
Why?
|
Cortical Spreading Depression | 2 | 2020 | 288 | 0.390 |
Why?
|
Cerebellum | 1 | 2019 | 1515 | 0.380 |
Why?
|
Adult | 60 | 2024 | 223542 | 0.370 |
Why?
|
Gadolinium | 4 | 2015 | 965 | 0.360 |
Why?
|
Migraine Disorders | 2 | 2014 | 1713 | 0.350 |
Why?
|
Humans | 94 | 2024 | 768451 | 0.340 |
Why?
|
Disability Evaluation | 9 | 2024 | 1839 | 0.310 |
Why?
|
Axons | 7 | 2024 | 1678 | 0.300 |
Why?
|
Demyelinating Diseases | 2 | 2022 | 359 | 0.290 |
Why?
|
Executive Function | 1 | 2016 | 1402 | 0.290 |
Why?
|
Motor Cortex | 5 | 2009 | 1015 | 0.290 |
Why?
|
Male | 60 | 2024 | 364781 | 0.290 |
Why?
|
Thrombocytopenia | 1 | 2015 | 1183 | 0.280 |
Why?
|
Hyperesthesia | 1 | 2007 | 23 | 0.280 |
Why?
|
Female | 60 | 2024 | 396943 | 0.270 |
Why?
|
Oxygen | 4 | 2015 | 4269 | 0.260 |
Why?
|
Middle Aged | 38 | 2024 | 223418 | 0.260 |
Why?
|
Carbon Radioisotopes | 2 | 2024 | 565 | 0.250 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2007 | 247 | 0.250 |
Why?
|
Memory | 2 | 2006 | 2210 | 0.250 |
Why?
|
Amygdala | 1 | 2013 | 1382 | 0.240 |
Why?
|
Attention | 2 | 2006 | 2423 | 0.230 |
Why?
|
Cerebral Veins | 2 | 2016 | 157 | 0.230 |
Why?
|
Energy Metabolism | 2 | 2014 | 2901 | 0.230 |
Why?
|
Cognition Disorders | 3 | 2015 | 3985 | 0.230 |
Why?
|
4-Aminopyridine | 1 | 2004 | 81 | 0.230 |
Why?
|
Synaptic Transmission | 2 | 2014 | 1173 | 0.220 |
Why?
|
Potassium Channel Blockers | 1 | 2004 | 162 | 0.220 |
Why?
|
Image Processing, Computer-Assisted | 12 | 2020 | 9066 | 0.220 |
Why?
|
Acetamides | 1 | 2024 | 260 | 0.200 |
Why?
|
Brain Stem | 1 | 2007 | 862 | 0.190 |
Why?
|
Cerebral Ventricles | 1 | 2024 | 551 | 0.190 |
Why?
|
Neuronal Plasticity | 4 | 2006 | 1448 | 0.190 |
Why?
|
Consensus | 2 | 2024 | 3207 | 0.180 |
Why?
|
Reproducibility of Results | 8 | 2022 | 20231 | 0.180 |
Why?
|
Prospective Studies | 9 | 2022 | 54914 | 0.180 |
Why?
|
Neuropsychological Tests | 6 | 2018 | 7134 | 0.170 |
Why?
|
Immunotherapy | 1 | 2015 | 4728 | 0.160 |
Why?
|
Motor Activity | 4 | 2005 | 2722 | 0.150 |
Why?
|
Gadolinium DTPA | 2 | 2004 | 823 | 0.140 |
Why?
|
Nerve Regeneration | 2 | 2019 | 801 | 0.140 |
Why?
|
Motor Neuron Disease | 1 | 2017 | 98 | 0.140 |
Why?
|
Myotonic Dystrophy | 2 | 2009 | 80 | 0.140 |
Why?
|
Fatigue | 2 | 2004 | 1556 | 0.130 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 828 | 0.130 |
Why?
|
Evoked Potentials, Motor | 3 | 2009 | 465 | 0.130 |
Why?
|
Encephalitis | 1 | 2019 | 441 | 0.120 |
Why?
|
Case-Control Studies | 5 | 2018 | 22293 | 0.120 |
Why?
|
Algorithms | 2 | 2014 | 14158 | 0.120 |
Why?
|
Sensitivity and Specificity | 4 | 2018 | 14728 | 0.120 |
Why?
|
Anisotropy | 1 | 2017 | 1296 | 0.110 |
Why?
|
Electromagnetic Phenomena | 1 | 2015 | 160 | 0.110 |
Why?
|
Afferent Pathways | 1 | 2014 | 304 | 0.110 |
Why?
|
Functional Laterality | 4 | 2015 | 2268 | 0.110 |
Why?
|
Blood-Brain Barrier | 1 | 1999 | 1034 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2888 | 0.100 |
Why?
|
Adjuvants, Immunologic | 3 | 2002 | 998 | 0.100 |
Why?
|
Neuroglia | 1 | 2017 | 961 | 0.100 |
Why?
|
Fibromyalgia | 1 | 2016 | 406 | 0.090 |
Why?
|
Corpus Callosum | 3 | 2022 | 755 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 3 | 2015 | 4077 | 0.090 |
Why?
|
Tomography, Optical Coherence | 1 | 2024 | 2958 | 0.090 |
Why?
|
Movement Disorders | 1 | 2015 | 464 | 0.090 |
Why?
|
Nociceptors | 1 | 2014 | 460 | 0.090 |
Why?
|
Prognosis | 4 | 2023 | 30028 | 0.080 |
Why?
|
Sleep Apnea Syndromes | 1 | 2017 | 981 | 0.080 |
Why?
|
Physical Stimulation | 2 | 2007 | 517 | 0.080 |
Why?
|
Touch | 2 | 2007 | 316 | 0.070 |
Why?
|
Carotid Stenosis | 1 | 2015 | 864 | 0.070 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2018 | 1472 | 0.070 |
Why?
|
Severity of Illness Index | 6 | 2018 | 15965 | 0.070 |
Why?
|
Phenotype | 1 | 2024 | 16712 | 0.070 |
Why?
|
Aged | 9 | 2024 | 171520 | 0.070 |
Why?
|
Trigeminal Nuclei | 1 | 2006 | 39 | 0.070 |
Why?
|
Cohort Studies | 4 | 2018 | 41797 | 0.070 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2009 | 367 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14766 | 0.060 |
Why?
|
Nerve Net | 1 | 2018 | 2362 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 26351 | 0.060 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39430 | 0.060 |
Why?
|
Neurons, Afferent | 1 | 2007 | 498 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3955 | 0.060 |
Why?
|
Image Enhancement | 1 | 2014 | 2894 | 0.060 |
Why?
|
Psychomotor Performance | 3 | 2007 | 1894 | 0.060 |
Why?
|
Age Distribution | 1 | 2009 | 2881 | 0.050 |
Why?
|
Risk | 1 | 2015 | 9642 | 0.050 |
Why?
|
Pain Threshold | 1 | 2007 | 606 | 0.050 |
Why?
|
Cognition | 2 | 2014 | 7066 | 0.050 |
Why?
|
Movement | 1 | 2009 | 1489 | 0.050 |
Why?
|
Young Adult | 6 | 2021 | 60045 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18478 | 0.050 |
Why?
|
Diffusion | 1 | 2024 | 818 | 0.050 |
Why?
|
Reaction Time | 2 | 2007 | 2102 | 0.050 |
Why?
|
Models, Neurological | 3 | 2009 | 1784 | 0.050 |
Why?
|
Magnetics | 1 | 2004 | 599 | 0.050 |
Why?
|
Pyramidal Tracts | 1 | 2002 | 252 | 0.050 |
Why?
|
Brain Chemistry | 2 | 2013 | 962 | 0.040 |
Why?
|
Disabled Persons | 3 | 2005 | 1218 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2009 | 15460 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7451 | 0.040 |
Why?
|
Hemostasis | 1 | 2022 | 470 | 0.040 |
Why?
|
Fibrin | 1 | 2022 | 515 | 0.040 |
Why?
|
Creatine | 1 | 2001 | 427 | 0.040 |
Why?
|
Electromyography | 1 | 2004 | 1399 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2001 | 577 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2000 | 343 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2020 | 376 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2103 | 0.040 |
Why?
|
Home Care Services | 1 | 2004 | 655 | 0.040 |
Why?
|
Mental Recall | 1 | 2004 | 1226 | 0.040 |
Why?
|
Estradiol | 1 | 2005 | 1949 | 0.040 |
Why?
|
Diffusion Tensor Imaging | 2 | 2019 | 2427 | 0.040 |
Why?
|
Memory, Short-Term | 1 | 2004 | 1009 | 0.040 |
Why?
|
Spinal Cord Diseases | 1 | 2019 | 293 | 0.030 |
Why?
|
Menstrual Cycle | 1 | 1999 | 542 | 0.030 |
Why?
|
Observer Variation | 2 | 2018 | 2622 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2015 | 65409 | 0.030 |
Why?
|
Apomorphine | 1 | 1995 | 150 | 0.030 |
Why?
|
Skull | 1 | 2020 | 832 | 0.030 |
Why?
|
Contrast Media | 4 | 2004 | 5336 | 0.030 |
Why?
|
Stroke | 1 | 2017 | 9791 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1348 | 0.030 |
Why?
|
Down-Regulation | 1 | 2002 | 2944 | 0.030 |
Why?
|
Testosterone | 1 | 2005 | 2493 | 0.030 |
Why?
|
Antibodies | 1 | 2002 | 2425 | 0.030 |
Why?
|
Electrocardiography | 1 | 2007 | 6410 | 0.030 |
Why?
|
Narcotics | 1 | 1995 | 337 | 0.030 |
Why?
|
Dopamine Agonists | 1 | 1995 | 353 | 0.030 |
Why?
|
Heart | 1 | 2006 | 4451 | 0.030 |
Why?
|
Organ Size | 1 | 2018 | 2268 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2002 | 1600 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2002 | 1891 | 0.030 |
Why?
|
Estrogens | 1 | 1999 | 1531 | 0.030 |
Why?
|
Pattern Recognition, Automated | 1 | 2018 | 998 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2002 | 1816 | 0.020 |
Why?
|
Caregivers | 1 | 2004 | 2302 | 0.020 |
Why?
|
Adolescent | 8 | 2020 | 89168 | 0.020 |
Why?
|
Paresis | 2 | 2002 | 177 | 0.020 |
Why?
|
Health Status | 1 | 2004 | 4096 | 0.020 |
Why?
|
Cocaine | 1 | 1995 | 960 | 0.020 |
Why?
|
Polysomnography | 1 | 2017 | 1864 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2004 | 12450 | 0.020 |
Why?
|
Rats | 2 | 2024 | 23839 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2018 | 6242 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 3783 | 0.020 |
Why?
|
Neurophysiology | 1 | 2009 | 145 | 0.020 |
Why?
|
Paresthesia | 1 | 2009 | 161 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2009 | 1489 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2659 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2015 | 81834 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6537 | 0.020 |
Why?
|
Recurrence | 1 | 1999 | 8510 | 0.020 |
Why?
|
Regression Analysis | 2 | 2007 | 6353 | 0.020 |
Why?
|
Reference Values | 2 | 2004 | 4941 | 0.020 |
Why?
|
Pons | 1 | 2006 | 242 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 13026 | 0.010 |
Why?
|
Mathematical Computing | 1 | 2004 | 142 | 0.010 |
Why?
|
Depression | 1 | 2004 | 8235 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8730 | 0.010 |
Why?
|
Trinucleotide Repeats | 1 | 2004 | 257 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 2009 | 1282 | 0.010 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2004 | 350 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22365 | 0.010 |
Why?
|
Motor Skills | 1 | 2006 | 522 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2007 | 1743 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2004 | 856 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12096 | 0.010 |
Why?
|
Animals | 3 | 2024 | 169418 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2004 | 916 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2002 | 624 | 0.010 |
Why?
|
Optic Neuritis | 1 | 2002 | 175 | 0.010 |
Why?
|
Patient Dropouts | 1 | 2002 | 411 | 0.010 |
Why?
|
Drug Tolerance | 1 | 2002 | 367 | 0.010 |
Why?
|
Hemodynamics | 1 | 2009 | 4202 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2004 | 1781 | 0.010 |
Why?
|
Parietal Lobe | 1 | 2002 | 866 | 0.010 |
Why?
|
Drug Interactions | 1 | 2002 | 1421 | 0.010 |
Why?
|
Hand | 1 | 2002 | 907 | 0.010 |
Why?
|
Steroids | 1 | 2002 | 937 | 0.010 |
Why?
|
Affect | 1 | 2004 | 1498 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1479 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2002 | 1315 | 0.010 |
Why?
|
Time Factors | 3 | 2002 | 40271 | 0.010 |
Why?
|
Deoxyglucose | 1 | 1995 | 333 | 0.010 |
Why?
|
Mice | 1 | 2022 | 82045 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4861 | 0.010 |
Why?
|
Patient Care Team | 1 | 2004 | 2526 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2002 | 6320 | 0.010 |
Why?
|
Acute Disease | 1 | 2002 | 7246 | 0.010 |
Why?
|
Sex Factors | 1 | 2005 | 10647 | 0.010 |
Why?
|
Software | 1 | 2004 | 4463 | 0.010 |
Why?
|
Neurons | 1 | 2009 | 9504 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2015 | 59680 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1995 | 8201 | 0.000 |
Why?
|
Blood Glucose | 1 | 1995 | 6429 | 0.000 |
Why?
|
Concepts
(228)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_